We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ultra-Portable Rapid Test Platform Offers Complete Sample-to-Answer Solution for Remote and Off-Grid Testing

By LabMedica International staff writers
Posted on 07 Jun 2023

An ultra-portable isothermal molecular diagnostics system integrated with a patented device which combines sample collection and processing into a single, easy-to-use disposable is set to revolutionize low-cost decentralized diagnostic testing. More...

ReadyGo Diagnostics’ (Bath, UK) Geo is a rapid test platform designed for small labs, pharmacies, and remote diagnostic needs. This highly portable device enables molecular tests to be run anywhere and delivers results in approximately 20 minutes. Designed to go anywhere, Geo uses ReadyGo’s Flex reagents which do not require cold-chain, making it a true off-grid, go-anywhere test platform. The platform also does not require a specialized operator or accurate pipetting thanks to its pre-measured reagents.

Combined with ReadyGo's innovative sample collection device, Snap, Geo offers a comprehensive solution for remote and off-grid testing of up to eight samples simultaneously. Snap, a compact, single-use device about the size of a highlighter pen, integrates sample collection and preparation. It uses a specialized material to absorb a specified amount of the patient's sample via capillary action, which is then mixed with a dried lysis reagent stored within the device. The reagent's components are similar to those in mouthwash, safe for human use, and highly effective at breaking down pathogens without inhibiting nucleic acid amplification reactions.

Operating the Snap device is simple: the user collects a sample, and bends the device to break an internal valve, releasing the exact amount of buffer required for the reaction into the chamber. Then, the user simply squeezes the bulb on the end of the device to release the contents for diagnostic testing. This simple sample preparation method also reduces the cost of the diagnostic assay, as it does not require any moving components. Snap eliminates the buffer measuring step, which some users found challenging when using over-the-counter lateral flow COVID-19 tests. When paired with Geo's eight-well isothermal amplification platform, the user can directly transfer Snap's contents into tubes pre-filled with assay reagents, then place the tubes in the Geo instrument for amplification and reading. Snap can be used with various samples, including saliva, nasal, buccal, and even surface samples, with ReadyGo also developing options for blood, urine, and stool sample collection.

ReadyGo has designed tests using recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP) for Geo's isothermal amplification and is currently developing its proprietary chemistry. The Geo platform is expected to be priced under USD 1,000, with individual assays costing around USD 10, making it a low-cost diagnostic solution for small labs and research groups. Additionally, the Geo system is designed for 3D printing in its manufacturing process, in line with ReadyGo’s goal to decentralize production and commercialization. This design will allow the system to be produced locally wherever testing is required and also provide the benefit of lower assembly costs in various parts of the world. The Geo system's streamlined design also reduces the need for plastics in its construction. ReadyGo aims to collaborate with other labs and companies, as well as develop tests that can be commercialized by its partners.

Related Links:
ReadyGo Diagnostics 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.